A citation-based method for searching scientific literature

Timothy M Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H Appel, Patricia L Andres, Katy Mahoney, Peggy Allred, Katie Alexander, Lyle W Ostrow, David Schoenfeld, Eric A Macklin, Daniel A Norris, Georgios Manousakis, Matthew Crisp, Richard Smith, C Frank Bennett, Kathie M Bishop, Merit E Cudkowicz. Lancet Neurol 2013
Times Cited: 385



Richard S Geary, Daniel Norris, Rosie Yu, C Frank Bennett. Adv Drug Deliv Rev 2015
Times Cited: 380




List of shared articles



Times cited


Antisense drug discovery and development technology considered in a pharmacological context.
Stanley T Crooke, Xue-Hai Liang, Rosanne M Crooke, Brenda F Baker, Richard S Geary. Biochem Pharmacol 2021
11

Antisense technology: A review.
Stanley T Crooke, Xue-Hai Liang, Brenda F Baker, Rosanne M Crooke. J Biol Chem 2021
14

Antisense technology: an overview and prospectus.
Stanley T Crooke, Brenda F Baker, Rosanne M Crooke, Xue-Hai Liang. Nat Rev Drug Discov 2021
21

Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting.
Grishma Pawar, Neha N Parayath, Aditya A Sharma, Carlos Coito, Olga Khorkova, Jane Hsiao, William T Curry, Mansoor M Amiji, Benjamin S Bleier. Front Pharmacol 2021
0

A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration.
Michael Monine, Daniel Norris, Yanfeng Wang, Ivan Nestorov. J Pharmacokinet Pharmacodyn 2021
1

Advances of Antisense Oligonucleotide Technology in the Treatment of Hereditary Neurodegenerative Diseases.
Mengsi Lin, Xinyi Hu, Shiyi Chang, Yan Chang, Wenjun Bian, Ruikun Hu, Jing Wang, Qingwen Zhu, Jiaying Qiu. Evid Based Complement Alternat Med 2021
1

Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders.
Ana C Silva, Diana D Lobo, Inês M Martins, Sara M Lopes, Carina Henriques, Sónia P Duarte, Jean-Cosme Dodart, Rui Jorge Nobre, Luis Pereira de Almeida. Brain 2020
18



Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
38

Antisense oligonucleotide therapies for Amyotrophic Lateral Sclerosis: Existing and emerging targets.
Joseph R Klim, Caroline Vance, Emma L Scotter. Int J Biochem Cell Biol 2019
7